Aaron Jonathan Deutsch, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vascular Grafting | 1 | 2017 | 160 | 0.560 |
Why?
|
| Amputation | 1 | 2017 | 791 | 0.450 |
Why?
|
| Cardiovascular Agents | 1 | 2017 | 863 | 0.400 |
Why?
|
| Ischemia | 1 | 2017 | 1934 | 0.340 |
Why?
|
| Decision Support Techniques | 1 | 2017 | 2029 | 0.300 |
Why?
|
| Peripheral Arterial Disease | 1 | 2017 | 1206 | 0.300 |
Why?
|
| Endovascular Procedures | 1 | 2017 | 1959 | 0.250 |
Why?
|
| Computer Simulation | 1 | 2017 | 6048 | 0.250 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 10857 | 0.180 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 2020 | 243 | 0.180 |
Why?
|
| Cardiology Service, Hospital | 1 | 2019 | 253 | 0.160 |
Why?
|
| Retreatment | 1 | 2017 | 628 | 0.140 |
Why?
|
| HLA-D Antigens | 1 | 2015 | 148 | 0.140 |
Why?
|
| Decision Trees | 1 | 2017 | 521 | 0.140 |
Why?
|
| HLA-C Antigens | 1 | 2015 | 168 | 0.140 |
Why?
|
| Markov Chains | 1 | 2017 | 991 | 0.120 |
Why?
|
| Indians, North American | 1 | 2017 | 363 | 0.120 |
Why?
|
| Granzymes | 1 | 2014 | 281 | 0.120 |
Why?
|
| Amino Acids | 2 | 2015 | 1752 | 0.110 |
Why?
|
| Patient Admission | 1 | 2019 | 1398 | 0.110 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2017 | 1592 | 0.100 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2015 | 1418 | 0.090 |
Why?
|
| Academic Medical Centers | 1 | 2019 | 2779 | 0.090 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2011 | 1095 | 0.080 |
Why?
|
| Viral Load | 1 | 2015 | 3231 | 0.080 |
Why?
|
| Phenotype | 2 | 2022 | 16306 | 0.080 |
Why?
|
| Host-Pathogen Interactions | 1 | 2015 | 1482 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2017 | 17218 | 0.070 |
Why?
|
| Stents | 1 | 2017 | 3312 | 0.070 |
Why?
|
| Cell Nucleus | 1 | 2014 | 3021 | 0.070 |
Why?
|
| RNA-Binding Proteins | 1 | 2014 | 1920 | 0.070 |
Why?
|
| Critical Illness | 1 | 2017 | 2496 | 0.070 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 2996 | 0.060 |
Why?
|
| African Americans | 1 | 2019 | 5118 | 0.060 |
Why?
|
| RNA | 1 | 2014 | 2680 | 0.060 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2011 | 1756 | 0.060 |
Why?
|
| Autoimmune Diseases | 1 | 2015 | 2117 | 0.060 |
Why?
|
| Epistasis, Genetic | 2 | 2015 | 374 | 0.060 |
Why?
|
| Comorbidity | 1 | 2017 | 10339 | 0.060 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 4988 | 0.060 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2017 | 3609 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3153 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3275 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2015 | 15485 | 0.050 |
Why?
|
| Neutrophils | 1 | 2014 | 3867 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 15252 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2015 | 3354 | 0.050 |
Why?
|
| Risk Factors | 5 | 2019 | 69553 | 0.050 |
Why?
|
| Pneumocystis carinii | 1 | 2020 | 69 | 0.050 |
Why?
|
| DNA | 1 | 2014 | 7172 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2019 | 23284 | 0.050 |
Why?
|
| Time Factors | 2 | 2019 | 41038 | 0.040 |
Why?
|
| Haplotypes | 2 | 2015 | 2874 | 0.040 |
Why?
|
| Lymphopenia | 1 | 2020 | 285 | 0.040 |
Why?
|
| HIV-1 | 1 | 2015 | 6757 | 0.040 |
Why?
|
| Alaska | 1 | 2017 | 65 | 0.040 |
Why?
|
| Citrulline | 1 | 2017 | 106 | 0.040 |
Why?
|
| Vimentin | 1 | 2017 | 276 | 0.040 |
Why?
|
| Heart Failure | 1 | 2019 | 10040 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2014 | 9774 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2011 | 3655 | 0.040 |
Why?
|
| Physical Chromosome Mapping | 1 | 2015 | 189 | 0.040 |
Why?
|
| Peptides, Cyclic | 1 | 2017 | 411 | 0.030 |
Why?
|
| Alleles | 2 | 2017 | 7090 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2015 | 327 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2019 | 61932 | 0.030 |
Why?
|
| HLA-B Antigens | 1 | 2015 | 386 | 0.030 |
Why?
|
| Humans | 10 | 2022 | 708843 | 0.030 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2020 | 2543 | 0.030 |
Why?
|
| Case-Control Studies | 3 | 2017 | 21194 | 0.030 |
Why?
|
| Arginine | 1 | 2017 | 944 | 0.030 |
Why?
|
| Receptors, CCR5 | 1 | 2015 | 442 | 0.030 |
Why?
|
| Inheritance Patterns | 1 | 2015 | 344 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2014 | 452 | 0.030 |
Why?
|
| Canada | 1 | 2017 | 1915 | 0.030 |
Why?
|
| Oncogene Protein v-akt | 1 | 2011 | 139 | 0.030 |
Why?
|
| Genotype | 2 | 2017 | 12863 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2011 | 412 | 0.030 |
Why?
|
| Female | 6 | 2020 | 375205 | 0.020 |
Why?
|
| K562 Cells | 1 | 2011 | 640 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2017 | 1976 | 0.020 |
Why?
|
| Inpatients | 1 | 2019 | 2207 | 0.020 |
Why?
|
| Health Status Disparities | 1 | 2019 | 1711 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2011 | 23950 | 0.020 |
Why?
|
| Middle Aged | 2 | 2019 | 213752 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2017 | 4293 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2017 | 6127 | 0.020 |
Why?
|
| Boston | 1 | 2019 | 9402 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 2709 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2019 | 2952 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2015 | 2587 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2011 | 3258 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2015 | 3539 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2014 | 4310 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2017 | 4383 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2011 | 1588 | 0.020 |
Why?
|
| Cell Division | 1 | 2011 | 4752 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2011 | 1712 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 4065 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 7089 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2011 | 8720 | 0.010 |
Why?
|
| Logistic Models | 1 | 2015 | 13468 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2011 | 3507 | 0.010 |
Why?
|
| Male | 4 | 2019 | 349524 | 0.010 |
Why?
|
| Aged | 2 | 2020 | 161488 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2015 | 11738 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2011 | 13314 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2011 | 10803 | 0.010 |
Why?
|
| Algorithms | 1 | 2015 | 13647 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 58184 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 12447 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2019 | 71483 | 0.010 |
Why?
|
| Adult | 1 | 2015 | 211041 | 0.000 |
Why?
|